Results 111 to 120 of about 210,101 (221)

Editorial: Recent Advances in Understanding the Pathogenesis of Shiga Toxin-Producing Shigella and Escherichia coli

Frontiers in Cellular and Infection Microbiology, 2020
Moo-Seung Lee, Moo-Seung Lee, Jang Won Yoon, Vernon L. Tesh   +3 more
doaj   +1 more source

Characterizing the frequency of clinical events and assessing biomarkers in propionic acidemia: a natural history study. [PDF]

Orphanet J Rare Dis
Schwahn BC, Berry GT, Vernon HJ, Li H, Merritt Ii JL, Schiff M, Chabrol B, De Las Heras J, Vockley J, Lee C, Koeberl DD, Burton BK, Grunewald S, Diaz GA, Ficicioglu C, Morgan T, Luo J, Attarwala H, Liang M, Perera S, Sikirica V.   +20 more
europepmc   +1 more source

Manuscrit de Vernon Lee numérisée et présentée à l'International Vernon Lee Society

EMAN, 2021
openaire   +1 more source

Impact of Vaccination-Differentiated Public Health and Social Measures on Vaccine Uptake Among the Vaccine Hesitant. [PDF]

AJPM Focus
Tan EJ, Chong C, Yap A, Chiew C, Tan S, Yang Y, Tan K, Lye D, Cook A, Lee V.   +9 more
europepmc   +1 more source

Understanding the role of age and U.S. acculturation factors on the relationship between allostatic load and cancer mortality risk in Hispanic Americans. [PDF]

Cancer Causes Control
Amezcua J, Miranda V, Lopez-Pentecost M, Islam JY, Vernon MM, O'Connor K, Moore JX.   +6 more
europepmc   +1 more source

Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial. [PDF]

J Immunother Cancer
Brohl AS, Sondak VK, Wuthrick EJ, Kim Y, Eroglu Z, Markowitz J, Tarhini AA, Fan W, Martin J, Sneed L, Perez MC, Sarnaik A, Harrington M, Neves RI, Gonzalez RJ, Cruse CW, Zager JS, Tsai KY, Khushalani NI.   +18 more
europepmc   +1 more source

First-line ipilimumab plus nivolumab in advanced merkel cell carcinoma: a meta-analysis of prospective trials and real-world validation cohort. [PDF]

Cancer Immunol Immunother
Ramadoss T, Palacios C, Nichols M, Eroglu Z, Markowitz J, Karapetyan L, Tarhini AA, Wuthrick EJ, Sondak VK, Tsai KY, Khushalani NI, Brohl AS.   +11 more
europepmc   +1 more source

Evolution of distinct subclones in a CALM-AF10-driven AML murine model results in leukemias with different phenotypes. [PDF]

Blood Neoplasia
Zandvakili N, Lee HM, Desai RH, Oryshchuk A, Browett PJ, Kakadia PM, Bohlander SK.   +6 more
europepmc   +1 more source

CFP Vernon Lee

SAGEF, 2013
openaire   +1 more source

Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma. [PDF]

Front Immunol
Karapetyan L, Kuriakose J, Perez MC, Ali JR, Hall MS, Beatty MS, Otteni CD, Xu J, Kalos D, Moran-Segura C, Vieira E, Adams K, Rodriguez-Alfonso L, DiMaggio EC, Bailey H, Pinilla-Ibarz J, Locke FL, Mullinax JE, Chen PL, Song J, Messina JL, Johnson DB, Morgan DS, Eroglu Z, Khushalani NI, Sondak VK, Sarnaik AA, Tsai K, Mulé JJ, Pilon-Thomas S.   +29 more
europepmc   +1 more source